Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca

Clinical trial NCT04988074 · RECRUITING

Trial details

NCT number

NCT04988074

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Status

RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2021-12-13

Primary completion

2027-06-30

Enrollment

32

View on ClinicalTrials.gov